News & Updates

Original New Drug Application Approvals by US FDA (16 - 28 February 2022)

03 Mar 2022

New drug applications approved by US FDA as of 16-28 February 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16 - 28 February 2022)

03 Mar 2022

Wearables detect seizures, help prevent related injuries

03 Mar 2022 by

The use of wearable devices is feasible for the automated seizure detection in the home environment, leading to better care outcomes, such as fewer seizure-related injuries and more accurate seizure diaries, according to a recent study.

Wearables detect seizures, help prevent related injuries

03 Mar 2022

Migraine drug yields preventive benefits across the board in episodic, chronic migraine

02 Mar 2022 by

Eptinezumab reduces migraine days for both episodic and chronic migraine patients, and the drug’s efficacy and safety profile are independent of age, sex, and body mass index, as shown in a study.

Migraine drug yields preventive benefits across the board in episodic, chronic migraine

02 Mar 2022

Quantitative sensory testing reliable for pain threshold, tolerance assessment

02 Mar 2022

Quantitative sensory testing (QST) yields reliable measures of pain threshold and tolerance, reveals a new study. However, measurements for sensitivity to changes in temperature are less reliable and may be affected by time and other contextual factors.

Quantitative sensory testing reliable for pain threshold, tolerance assessment

02 Mar 2022

Mucolytics, ICS/LABA combinations cut stroke risk among COPD patients with allied conditions

02 Mar 2022

Patients with chronic obstructive pulmonary disease (COPD) and allied conditions are at heightened risk of stroke, but treatment with mucolytic agents and the combination of inhaled corticosteroids (ICS) plus long-acting β2-agonists (LABA) may protect against the risk, as shown in a study.

Mucolytics, ICS/LABA combinations cut stroke risk among COPD patients with allied conditions

02 Mar 2022

Genes related to general cognition exert no influence on age-related cognitive decline

27 Feb 2022

Common genetic variants associated with general cognition contribute to better verbal memory and semantic fluency in adults, according to a study. However, they appear to have a null effect on age-related cognitive decline.

Genes related to general cognition exert no influence on age-related cognitive decline

27 Feb 2022

Maternal stroke tied to high morbidity, mortality

25 Feb 2022 by

Women who experienced a stroke during pregnancy had higher rates of morbidity and mortality compared with those without stroke, according to a study presented at ISC 2022.

Maternal stroke tied to high morbidity, mortality

25 Feb 2022

DOACs as effective as warfarin for CVT with lower bleeding risk

24 Feb 2022 by

The risk of recurrent venous thrombosis in patients with cerebral venous thrombosis (CVT) was comparable between those who received warfarin or direct oral anticoagulants (DOACs), according to results of the ACTION-CVT* study presented at ISC 2022.

DOACs as effective as warfarin for CVT with lower bleeding risk

24 Feb 2022

Tenecteplase still feasible up to 24 hours after a stroke

24 Feb 2022 by

Intravenous thrombolysis with tenecteplase up to 24 hours after a stroke appears to re-establish blood flow in patients with large-vessel acute ischaemic stroke selected with advanced imaging, the phase IIa CHABLIS-T study has shown.

Tenecteplase still feasible up to 24 hours after a stroke

24 Feb 2022

High BP in young adulthood tied to brain changes in midlife

22 Feb 2022 by

Having high blood pressure (BP) during age 20-40 years appears to be associated with brain changes in midlife which may increase the risk of cognitive decline in later life, according to data from the Coronary Artery Risk Development in Young Adults (CARDIA) study presented at ISC 2022.

High BP in young adulthood tied to brain changes in midlife

22 Feb 2022

News & Updates

Filter by Specialty:

Specialty:

Original New Drug Application Approvals by US FDA (16 - 28 February 2022)

Original New Drug Application Approvals by US FDA (16 - 28 February 2022)

Wearables detect seizures, help prevent related injuries

Wearables detect seizures, help prevent related injuries

Migraine drug yields preventive benefits across the board in episodic, chronic migraine

Migraine drug yields preventive benefits across the board in episodic, chronic migraine

Quantitative sensory testing reliable for pain threshold, tolerance assessment

Quantitative sensory testing reliable for pain threshold, tolerance assessment

Mucolytics, ICS/LABA combinations cut stroke risk among COPD patients with allied conditions

Mucolytics, ICS/LABA combinations cut stroke risk among COPD patients with allied conditions

Genes related to general cognition exert no influence on age-related cognitive decline

Genes related to general cognition exert no influence on age-related cognitive decline

Maternal stroke tied to high morbidity, mortality

Maternal stroke tied to high morbidity, mortality

DOACs as effective as warfarin for CVT with lower bleeding risk

DOACs as effective as warfarin for CVT with lower bleeding risk

Tenecteplase still feasible up to 24 hours after a stroke

Tenecteplase still feasible up to 24 hours after a stroke

High BP in young adulthood tied to brain changes in midlife

High BP in young adulthood tied to brain changes in midlife